Cite

HARVARD Citation

    Gao, X. et al. (2012). Impact of adverse events on costs and quality of life in protease inhibitor-based combination therapy for hepatitis C. Expert review of pharmacoeconomics & outcomes research. pp. 335-343. [Online]. 
  
Back to record